跳至主要内容
临床试验/CTRI/2024/03/064441
CTRI/2024/03/064441招募中4 期

A Prospective, Open label, Randomized, Controlled, Three-Arm, Comparative Study to Determine the Effect of high protein supplement on muscle strength, muscle mass and physical function in elderly population.

Hindustan Unilever Limited3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年3月28日最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
120
试验地点
3
主要终点
To determine the effect of a protein supplement with lifestyle counselling versus lifestyle counselling alone on muscle strength or physical function on elderly participants after a 12 week period of consumption.

研究概览

简要总结

The study is a  randomized, open label, controlled, parallel, three arm study.  One twenty adults men and women aged greater than or equal to 60 years or above with body mass index BMI between 20.0 and 32.5 kg/m2 will be included in the study. Each arm will have 40 participants. The protein supplementation will be given for 24 weeks post randomization. Participants will be divided into 3 equal groups comprising 40 participants each. The 3 groups will be assigned to either of the 3 arms (1, 2, 3) sequenced according to the randomization schedule and subject has to visit at site on Day 1, Day 28, Day 56, Day 84, Day 112, Day 140 and Day 168 .

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
60.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • 1.Physically independent mobile men and post menopausal women above or equal to 60 years of age who are able to rise from a seated position to standing will be considered 2.All participants below the cutoff for 30 second Chair Stand test 30CST will be included in the study 30SCST cutoffs more than 9 for men and more than 8 for women to be considered 3.Participants having normal resting blood pressure or stage I hypertension systolic blood pressure BP greater than or equal to greater than or equal to 130 to 139 mmHg diastolic BP greater than or equal 80 to 89 mmHg will be considered 4.Participants having BMI 20 to 32.5 kg per m2 will be considered 5.Participants or diabetics on stable doses of oral hypoglycemic agents OHA for at least the last 3 months with glycated hemoglobin HbA1C less than or equal to 8 percent will be considered 6.Participants with a normal liver function and or kidney function and CBC or abnormal values which are considered clinically non significant as per investigator 7.The potential participant should not be on any structured resistance or aerobic exercise training program in the previous 6 months 8.Participants should be willing and able to follow the study protocol and protocol related procedures to participate in the study 9.Participants who can understand and provide written informed consent to participate in the study.

排除标准

  • Participants who have had significant weight loss or gain in the past 6 months.
  • Participants having history of having cancer, infectious diseases, unstable cardiac, and/or gastrointestinal disease or poorly controlled diabetes or on insulin injections for diabetes or having alterations of dosages of OHA in the last 3 months.
  • Participants who regularly uses non-steroidal anti-inflammatory drugs or anticoagulants.
  • Participant with any known food allergy (particularly milk) or intolerance to any food or beverages.
  • Any participant who has taken part in a clinical trial in the past 90 days.
  • Participants on an unusual diets or special diet, for whatever reason e.g., keto diet or any other high protein diet, low sodium diet, for two weeks prior to receiving any test product and throughout his/her participation in the study will be excluded.
  • Participants who have had any surgery in the past 6 months will be excluded.
  • Potential participants who are related (e.g., husband and wife or brother and sister) or persons living in the same household (e.g., tenants sharing a household) cannot be recruited together in this study; one of them will be excluded.
  • The participant(s) must also not be related to any personnel conducting the study.
  • Participants consuming non-vegetarian foods (more than 2 a week) in their habitual diet.

结局指标

主要结局

To determine the effect of a protein supplement with lifestyle counselling versus lifestyle counselling alone on muscle strength or physical function on elderly participants after a 12 week period of consumption.

时间窗: Subject will visit at site on Day 1, Day 28, Day 56, Day 84, Day 112, Day 140 and Day 168

次要结局

  • 1. To determine the effect of a protein supplement with lifestyle counselling versus lifestyle counselling alone on muscle strength or physical function on elderly participants after a 24 week & period of consumption.(2. To determine the effect of a protein supplement with lifestyle counselling versus lifestyle counselling alone on muscle mass on elderly participants after 12- & 24-week of consumption.)

研究者

申办方类型
Pharmaceutical industry-Global
责任方
Principal Investigator
主要研究者

Dr Sanjay Mishra

Rumedic Hospital

研究点 (3)

Loading locations...

相似试验